Human Molecular Genetics Advance Access published online on November 29, 2006
Human Molecular Genetics, doi:10.1093/hmg/ddl442
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2006. Published by Oxford University Press. All rights reserved
APC mutations in FAP-associated desmoid tumours are non-random but not ‘just right’
1 Polyposis Registry, Cancer Research UK, St Mark's Hospital, Harrow, Middlesex HA1 3UJ, UK 2 Colorectal Cancer Genetics, Cancer Research UK, St Mark's Hospital, Harrow, Middlesex HA1 3UJ, UK 3 ICMS, Barts and The London Queen Mary's School of Medicine and Dentistry, 4 Newark Street, London, E1 2AT, UK 4 Molecular and Population Genetics Laboratory, London Research Institute, Cancer Research UK, London, WC2A 3PX, UK
* Correspondence to: Prof. Andrew Silver, Institute of Cell and Molecular Science, Barts and The London, Queen Mary's School of Medicine and Dentistry, 4 Newark Street, London, E1 2AT Tel: 0207 882 2590 Fax: 0207 882 2200 Email: a.r.silver{at}qmul.ac.uk
Received September 15, 2006; Revised November 7, 2006; Accepted November 16, 2006
Analysis of APC mutations in colonic and duodenal tumours from familial adenomatous polyposis (FAP) patients has shown that the site of the first hit, the germline mutation, can predict the type and position of the somatic mutation or ‘second hit’. The two APC mutations are selected on the basis of a ‘just right’ level of beta-catenin signalling in intestinal tumours achieved through retention of some of the seven 20-amino-acid beta-catenin degradation repeats. Desmoids are a life threatening extra-colonic manifestation in FAP patients. These aggressive tumours of mesenchymal origin are, at present, poorly characterised in terms of mutational APC spectra. We have investigated somatic mutations in the largest cohort of FAP-associated desmoids to date, and combined our results with previously published data. Somatic mutations were found to occur non-randomly and the position of the germline mutation shown to be a major determinant of the somatic mutation, a characteristic shared with intestinal tumours from FAP patients. In contrast to colonic polyps, loss of heterozygosity in desmoids involved deletion rather than mitotic recombination. Whilst tumours from the colorectum and upper gastrointestinal tract usually retain 1-2 and 3-4 beta-catenin degradation repeats respectively, most desmoids preferentially retain 2 repeats (p<0.001, 
2 test). In addition, most desmoids with two APC hits (87%, 26/30) had one mutated allele with no 20-amino acid repeats (p<0.001). This feature, unique among FAP tumours, indicates that a mutation deleting all repeats from one allele may be an important component in maintaining appropriate levels of beta-catenin signalling levels in desmoid tumour cells.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. M. Kohler, S. H. V. Chandra, J. Behrens, and J. Schneikert {beta}-Catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours Hum. Mol. Genet., January 15, 2009; 18(2): 213 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J.F. Lazar, D. Tuvin, S. Hajibashi, S. Habeeb, S. Bolshakov, E. Mayordomo-Aranda, C. L. Warneke, D. Lopez-Terrada, R. E. Pollock, and D. Lev Specific Mutations in the {beta}-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid Tumors Am. J. Pathol., November 1, 2008; 173(5): 1518 - 1527. [Abstract] [Full Text] [PDF]
|
|